Nabriva Therapeutics plc Gains 33.91%

Fri 29 May 20 at 05:30 PM
Nabriva Therapeutics plc Gains 33.91%

Nabriva Therapeutics plc (NBRV:NASDAQ) shot up at $1.14, representing a gain of 33.9%. On Thu 28 May 20, NBRV:NASDAQ hit a New 2-Week High of $0.85. The stock appeared on our News Catalysts scanner on Fri 29 May 20 at 08:35 AM in the 'BIOTECH' category. From Thu 14 May 20, the stock recorded 88.89% Up Days and 60.00% Green Days

About Nabriva Therapeutics plc (NBRV:NASDAQ)

Nabriva Therapeutics AG is engaged in the research and development of novel anti-infective agents to treat serious infections, with a focus on the pleuromutilin class of antibiotics.

Share